Shiseido EBITDA 2012-2026 | SSDOY
Shiseido annual and quarterly EBITDA history from 2012 to 2026. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- Shiseido EBITDA for the quarter ending June 30, 2026 was $0.191B, a 3.7% decline year-over-year.
- Shiseido EBITDA for the twelve months ending June 30, 2026 was $0.642B, a 10.24% decline year-over-year.
- Shiseido 2025 annual EBITDA was $0.573B, a 7.96% increase from 2024.
- Shiseido 2024 annual EBITDA was $0.531B, a 27.42% decline from 2023.
- Shiseido 2023 annual EBITDA was $0.731B, a 21.14% decline from 2022.
|
Shiseido Annual EBITDA (Millions of US $) |
|
|---|---|
| 2025 | $573 |
| 2024 | $531 |
| 2023 | $731 |
| 2022 | $927 |
| 2021 | $1,014 |
| 2020 | $775 |
| 2019 | $1,585 |
| 2018 | $1,372 |
| 2017 | $1,099 |
| 2016 | $654 |
| 2015 | $619 |
| 2014 | $598 |
| 2013 | $878 |
| 2012 | $769 |
| 2011 | $957 |
|
Shiseido Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2026-03-31 | $191 |
| 2025-03-31 | $166 |
| 2024-03-31 | $68 |
| 2023-03-31 | $217 |
| 2022-03-31 | $199 |
| 2021-03-31 | $102 |
| 2020-03-31 | $60 |
| 2019-03-31 | $354 |
| 2018-03-31 | $434 |
| 2017-03-31 | $212 |
| 2016-03-31 | $192 |
| 2015-06-30 | $107 |
| 2015-03-31 | $2,211 |
| 2014-12-31 | $1,842 |
| 2014-09-30 | $1,914 |
| 2014-06-30 | $8 |
| 2014-03-31 | $2,596 |
| 2013-12-31 | $1,749 |
| 2013-09-30 | $2,001 |
| 2013-06-30 | $80 |
| 2013-03-31 | $2,425 |
| 2012-12-31 | $1,859 |
| 2012-09-30 | $2,339 |
| 2012-06-30 | $-38 |
| 2012-03-31 | $2,746 |
| 2011-12-31 | $2,026 |
| 2011-09-30 | $2,300 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Consumer Staples | Cosmetics and Toiletries | $8.834B | $6.488B |
| SHISEIDO CO., LTD. is a Japan-based company engaged in the manufacturing and sale of cosmetics, toiletries, beauty products, health foods, beauty foods and pharmaceuticals. The Company operates in three business segments. The Domestic Cosmetics segment offers cosmetics, toiletries, beauty products, health foods, beauty foods and pharmaceuticals to the domestic market, as well as provides mail order service. The Overseas Cosmetic segment offers cosmetics, toiletries and beauty products to overseas markets. The Others segment is engaged in the the manufacture and sale of cosmetics materials, pharmaceuticals for medical uses and aesthetic medical cosmetics, the sale of clothing and miscellaneous goods, the management and sale of real estates, as well as the restaurant business. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Estee Lauder (EL) | United States | $34.588B | 38.09 |
| DSM Firmenich AG - (DSFIY) | Switzerland | $26.555B | 0.00 |
| E.l.f Beauty (ELF) | United States | $5.512B | 34.60 |
| Coty (COTY) | United States | $2.316B | 12.52 |
| POLA ORBIS (PORBF) | Japan | $1.704B | 16.04 |
| Helen Of Troy (HELE) | Bermuda | $0.634B | 11.39 |
| European Wax Center (EWCZ) | United States | $0.317B | 8.20 |
| Nu Skin Enterprises (NUS) | United States | $0.223B | 4.72 |
| Pitanium (PTNM) | Hong Kong, SAR China | $0.208B | 0.00 |
| Waldencast (WALD) | United Kingdom | $0.147B | 0.00 |
| Empro Group (EMPG) | $0.141B | 0.00 | |
| Solesence (SLSN) | United States | $0.062B | 0.00 |
| Natura &Co Holding S.A ADR (NTCOY) | Brazil | $0.000B | 0.00 |